Seidenberg Beth C: insider trades.
Seidenberg Beth C reported 7 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
- Transactions
- 7
- Purchases (P)
- 0
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- SEIDENBERG BETH C
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | Director, TenPercentOwner | 7 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-10 | Latigo Biotherapeutics, Inc. | C | 2,066,857 | — | 2,094,813 | Form 4 |
| 2026-08-10 | Latigo Biotherapeutics, Inc. | C | 165,519 | — | 5,160,847 | Form 4 |
| 2026-08-10 | Latigo Biotherapeutics, Inc. | C | 1,484,401 | — | 4,995,328 | Form 4 |
| 2026-08-10 | Latigo Biotherapeutics, Inc. | C | 3,464,072 | — | 3,510,927 | Form 4 |
| 2026-08-10 | Latigo Biotherapeutics, Inc. | C | 1,027,635 | — | 5,944,009 | Form 4 |
| 2026-08-10 | Latigo Biotherapeutics, Inc. | C | 938,979 | — | 1,368,532 | Form 4 |
| 2026-08-10 | Latigo Biotherapeutics, Inc. | C | 3,547,842 | — | 4,916,374 | Form 4 |
Questions
What stock did Seidenberg Beth C buy or sell?
Seidenberg Beth C reported 7 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
Is Seidenberg Beth C the same person as other filers with this name?
This page covers SEC CIK 1184592 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/seidenberg-beth-c-1184592.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.